Analyst Team

Sherry Grisewood, CFA, Managing Partner, Life Sciences Research

Sherry has  over 20 years  experience as a research professional acting in  a wide variety of equity investment and corporate-directed research activities,  primarily for  early stage life science and related  technology  companies.   Through her extensive corporate and academic  contact, Sherry has developed  particular focus in areas of intersecting technologies such as  regenerative medicine,  nucleic acid based technologies, immunotherapy and therapeutic medical devices  currently under development by  US and  ex-US life science companies.

In former analyst capacities,  Sherry has served  as an independent life science analyst for several regional broker dealers, served as  Vice President, Senior Investment Banking analyst for  Jesup Lamont Securities, was a founding analyst/Director of Life Science Research for a leading  independent investment research company  and acted as Director of Research for Gilford Securities. Prior to becoming an equity analyst, Sherry developed and published stock index futures and equity options trading strategies. In addition to publishing equity research, Sherry provided daily market commentary for almost 15 years, was a regular commentator on Wall Street Journal Radio  and All Nippon  News as well as provided market-close  radio  commentary for a syndicate of 21 radio stations in the Southeast US.

Sherry holds a Bachelor of Science degree with Highest Honors    from Ramapo College of New Jersey and   the  Chartered Financial Analyst designation. Sherry is a member of the CFA Institute, NY Society of Security Analysts, and an individual member of the European Federation of Biotechnology, the   Tissue Engineering and Regenerative Medicine Society International (TERMIS), the Society of Biomaterials and the American Society of Gene  and Cell Therapy.